Top 300 Pharmacy Drug Cards

VALSARTAN: Diovan

Class: Angiotensin II Receptor Antagonist

Dosage Forms. Tablet: 40 mg, 80 mg, 160 mg, 320 mg

Image

Common FDA Label Indication, Dosing, and Titration.

1. Heart failure: 40 mg po bid, may titrate to 320 mg/d

2. Hypertension: 80-160 mg po daily, may titrate to 320 mg po daily

3. Myocardial infarction: 20 mg po bid, may titrate to 320 mg po daily

Off-Label Uses.

1. Diabetes mellitus, prophylaxis: 80-160 mg po daily

2. Diabetic nephropathy: 40-80 mg po daily

MOA. Valsartan is a selective, reversible, competitive antagonist of the angiotensin II receptor (AT1), which is responsible for the physiologic effects of angiotensin II including vasoconstriction, aldosterone secretion, sympathetic outflow, and stimulation of renal sodium reabsorption.

Drug Characteristics: Valsartan

Image

Medication Safety Issues: Valsartan

Image

Drug Interactions: Valsartan

Image

Adverse Reactions: Valsartan

Image

Efficacy Monitoring Parameters. Decreased BP, signs/symptoms of CHF.

Toxicity Monitoring Parameters. Signs/symptoms of hypotension, tachycardia, angioedema (swelling of the face, eyes, lips, tongue, or throat), hyper-kalemia (confusion, body weakness, uneven heartbeat, or numbness/tingling in hands or feet), reduction in urination, jaundice, or skin rash. Monitor vital signs, weight, LFTs.

Key Patient Counseling Points. Do not discontinue abruptly. Use potassium supplements or salt substitutes only under medical supervision. This medicine may cause dizziness. Avoid driving, using machinery, or doing anything else that could be dangerous if not alert. Recommend avoiding alcohol and NSAIDs while taking this drug.

Clinical Pearls. Angiotensin II receptor antagonists can cause injury or death to the developing fetus when used during 2nd and 3rd trimesters. Therapy should be stopped as soon as possible when pregnancy is detected. Blood chemistry, serum electrolytes, and renal function tests should be conducted prior to therapy initiation and monitored periodically thereafter.